Delivery Order SPE2DB20D3505-SPE2DB25FT7U8

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The firm-fixed-price contract, valued at $4,749.84, has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,909.38, is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. It is a firm fixed-price contract with a completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,572.86 firm fixed-price contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,985.18 firm fixed price contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which is a specialty medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,061.24 fixed-price delivery order is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 firm fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.07 firm fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of August 1, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,546.80 firm fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,046.44 firm fixed-price contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,686.12 delivery order contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a firm fixed price structure and an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT7U8
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,246.75 firm fixed-price contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:05 AM